🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣Attn: Gyn Onc fellows and attendings - Interview season is here! Any words of wisdom for myself and other applicants as we set out on the trail❔#fellowship #interviewtips #gynonc

Be yourself, be honest and really want to do this…

Samantha Leite Get to know your co-interviewees, they’ll be your colleagues for life! Best of luck!

Samantha Leite Be genuine!! Don’t worry about what you think they want you to answer, answer honestly. You want to be at a place that wants you for you. Good luck!!

Samantha Leite Best wishes! Prepare for❓on your “why” for gyn onc & program qualities you’re looking for. Do your homework on programs/faculty you’re interviewing with; it shows sincere interest. Join SGO to take advantage of fellowship interview and great resources/mentor opportunities!

Samantha Leite Agree with be honest and yourself, but you need to also be prepared. Know something about the programs you chose to interview and why. Actively work into your discussions what makes you stand out. (I give my trainees 4 things to get across, but no room here)

Beryl Manning-Geist, MD Samantha Leite I second this one. 15 years later, my co-interviewees from the trail are my favorite colleagues that I look forward to seeing at SGO every year.

Samantha Leite Have fun - meet new friends - learn the field and find the right fit to train… take time to answer questions and have some questions prepared that are program specific

When cancer starts in the uterus, it's called #UterineCancer. The most common type occurs when abnormal cells grow in the endometrium. A much rarer type is uterine sarcoma, which forms in the muscles and supporting tissues of the uterus. igcs.org/ucam/

It’s good to be back 🤖#UterineCancerAwarenessMonth #gynonc #roboticsurgery

Fantastic work by Beryl Manning-Geist, MD evaluating ongoing research to leverage unique features of low-grade serous carcinoma in an effort to refine treatment options for patients with this rare tumor subtype. Róisín O’Cearbhaill and Rachel Grisham, MD Team Ovary, Memorial Sloan Kettering Cancer Center pubmed.ncbi.nlm.nih.gov/38805312/

In my chief era 💁🏼‍♀️✨

Wow, the GREAT news continues for drug approvals in endometrial cancer! Today, pembro+chemo FDA-approved for pts w/ dMMR AND pMMR advanced/recurrent disease! This is historic & progress for our pts; honored to be part of the study team! Congrats ⁦Ramez Eskander⁩, ⁦NRG Oncology⁩

It’s never easy saying goodbye to patients going home with hospice…and I hope it never becomes easy. “It’s been an honor to care for you” ♥️

We were proud to give Larry Copeland, MD, a big hand after his final surgery at The James. 👏👏👏 Congrats to Dr. Copeland on more than four decades of surgical expertise. We can't thank him enough for all he's done—and continues to do—for Ohio State's #GynOnc patients.

First in-person interview since applying for medical school 😱 #fellowship #gynonc

Excited to share our QI paper published in AJOG. If you’re not already adding metronidazole to cefazolin for SSI prophylaxis in Gyn surgery, you should start! Adjusted OR for SSI 0.49 ⬇️ with addition of metronidazole. Jolyn Taylor Kathleen Schmeler MD MD Anderson Cancer Center

Happy match day to all my fellow Gyn Oncology applicants 🌟

🔥The dynamic duo Drs. Rebecca Stone and Kara Long leading our 🇺🇸 efforts in opportunistic #salpingectomy to reduce #ovariancancer. Hear their SGO post-session updates! #SGOMtg #SGO2025 Karen Lu